MSB 2.17% $1.13 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-490

  1. 12,429 Posts.
    lightbulb Created with Sketch. 3371
    4 months, but it may be quicker
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.